Shares of Jubak Pick Acadia Pharmaceuticals pop 11% on buyout rumors
Update January 4. Shares of Acadia Pharmaceuticals (ACAD) were up 12% this morning, January 4, before closing with a gain of 11.02% to $31.94. The action came on rumors that Pfizer (PFE) or another big drug company would make a bid for the biotech on the strength of...
Acadia Pharmaceuticals is my first Trump stock pick
The big test for Acadia Pharmaceuticals (ACAD) this quarter certainly wasn’t earnings. As an early stage biotech losses are expected and that’s exactly what the company delivered when it reported third quarter results on November 7. The loss came to 61...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!